As of 06 Nov 2026 13:32 UTC. Status is always as stated in the latest recorded notice; the sources do not publish resolution, so nothing on this page says a medicine is back — see methodology.
Presentations, as stated in the latest recorded notice
Each line is re-expressed from MSN/2025/041 (04 Jul 2025): the product named, the status the source stated, and the expected-back phrase kept as written. Not the source's sentence, and not an observation of stock.
| Presentation | Status, as stated | Expected back, as stated | Stated in |
|---|---|---|---|
| Salbutamol (Salamol Easi-Breathe®) 100micrograms/dose breath actuated inhaler CFC freeaffected product · inferred from phrasing | Out of stock, as stated | mid-September 2025precision: mid-month · window end 20 Sep 2025, derived from “mid-September 2025” | notice of 04 Jul 2025 |
| Salbutamol (Airomir®) 100micrograms/dose breath actuated inhaler CFC freeaffected product · inferred from phrasing | Discontinued, as stated | — not stated for this line | notice of 04 Jul 2025 |
| Salbutamol (Salamol®) 100micrograms/dose inhaler CFC free pressurised metered-dose inhaler (pMDIs)named by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 04 Jul 2025 |
| Salbutamol (Easyhaler®) 100micrograms/dose dry powder inhaler (DPI)named by the source as remaining available · inferred from phrasing | Stated as available | — not stated for this line | notice of 04 Jul 2025 |
| Salbutamol (Ventolin Evohaler®) 100microgram/dose inhaler CFC free pMDI and salbutamol (Salbulin Novolizer®) 100micrograms/dose inhalation powdernamed by the source as remaining available · inferred from phrasing | Stated as available; cannot support an uplift in demand | — not stated for this line | notice of 04 Jul 2025 |
Protocol in force
No Serious Shortage Protocol matched to this name is in force on the NHSBSA register. Matching is by name until identifier coding lands.
Named in the source as remaining available
- Salbutamol (Salamol®) 100micrograms/dose inhaler CFC free pressurised metered-dose inhaler (pMDIs) — named by the source as remaining available (inferred from phrasing)
- Salbutamol (Easyhaler®) 100micrograms/dose dry powder inhaler (DPI) — named by the source as remaining available (inferred from phrasing)
- Salbutamol (Ventolin Evohaler®) 100microgram/dose inhaler CFC free pMDI and salbutamol (Salbulin Novolizer®) 100micrograms/dose inhalation powder — named by the source as remaining available (inferred from phrasing)
Only names the source itself listed, as it listed them (source post ↗). No substitution, dosing or counselling advice is given here or implied.
Identifiers — Salbutamol
BNF chemical and SNOMED identifiers from NHSBSA Prescription Cost Analysis (Open Government Licence), matched by name (presentation name), confidence 0.90 — grouping under review where marked Release Jul 2026.
BNF SNOMED mapping, NHSBSA Copyright 2026; Prescription Cost Analysis (PCA) Monthly Administrative Data, NHSBSA Copyright 2026. This information is licenced under the terms of the Open Government Licence.
History
Notified short 5 times on record since 2024 — a recurring shortage spanning 1.4 years. We record when a shortage is declared, not when stock returns — the source doesn't publish that. An update sharing a reference counts as one episode.
| Issued | Notice | Kind | Tier | Reference |
|---|---|---|---|---|
| 04 Jul 2025 | Medicine Supply Notification: Salbutamol 100micrograms/dose breath actuated inhalers CFC free | Supply notification | Tier 2 | MSN/2025/041 |
| 06 Mar 2025 | Medicine Supply Notification: Salbutamol (Salamol Easi-Breathe®) 100micrograms/dose breath actuated inhaler CFC free | Supply notification | Tier 2 | MSN/2025/014 |
| 23 May 2024 | Medicine Supply Notification: Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials | Supply notification | Tier 2 | MSN/2024/059 |
| 06 Mar 2024 | Medicine Supply Notification: Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials | Supply notification | Tier 2 | MSN/2024/028 |
| 26 Feb 2024 | National Patient Safety Alert DHSC: Shortage of salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials - Updated | Safety alert | — | MSN/2024/028 |
| 21 Feb 2024 | Medicine Supply Notification: Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials | Supply notification | Tier 3 | MSN/2024/021 |
Also recorded under
Bracketed names seen in this medicine's notice titles: salamol. Grouping is by the head name in each title; brand and generic names may still sit on separate pages until identifier coding refines it — see the A–Z.
Scotland — separate record
NHS Scotland issues its own Medicine Supply Alert Notices. These match this medicine's name; they are shown beside, never added to, the England record.
- MSAN(2025)33 Salbutamol 100micrograms/dose breath actuated inhalers CFC free · issued 11 Jul 2025 · valid until December 2025, as stated · matched by name PDF ↗
- MSAN(2025)11 Salbutamol (Salamol Easi-Breathe®) 100micrograms/dose breath actuated · issued 26 Mar 2025 · valid until early April 2025, as stated · matched by name PDF ↗
- MSAN(2024)29 Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials · issued 30 May 2024 · valid until TBC, as stated · matched by name PDF ↗
- MSAN(2024)7 Salbutamol 2.5mg/2.5ml nebuliser liquid unit dose vials - Update · issued 08 Mar 2024 · valid until late June 2024, as stated · matched by name PDF ↗
- MSAN(2024)4 Salbutamol 2.5mg/2.5ml and 5mg/2.5ml nebuliser liquid unit dose vials · issued 29 Feb 2024 · valid until TBC, as stated · matched by name PDF ↗
- MSAN(2020)12 Salbutamol 2mg/5mL syrup – update to MSAN (2020)5 · issued 06 Mar 2020 · valid until end March 2020, as stated · matched by name PDF ↗
- MSAN(2020)5 Salbutamol 2mg/5mL syrup · issued 12 Feb 2020 · valid until end February 2020, as stated · matched by name PDF ↗